Gain access to exclusive preclinical content.
Complete the form below. We'll assign a user name and password, then send you a link. Thanks!

Get Access Register

EXCLUSIVE PRECLINICAL CONTENT.
You must log in to access content on this page. Or click here to request access.
Clinical validation of the novel fluorescent glomerular filtration rate tracer agent relmapirazin (MB-102)

Richard B. Dorshow, Martin P. Debreczeny, Stuart L. Goldstein and Jeng-Jong Shieh,"Clinical validation of the novel fluorescent glomerular filtration rate tracer agent relmapirazin (MB-102)", Kidney International, 17 June 2024, https://doi.org/10.1016/j.kint.2024.06.012.